Morphocell Technologies logo

Morphocell Technologies

Transforming the treatment of liver disease

VS
(株)ステムリム logo

(株)ステムリム

Pioneering regenerative medicine by harnessing the body's own stem cells to repair and rejuvenate damaged tissues.

Side-by-Side Comparison

Metric Morphocell Technologies (株)ステムリム
Founded 2018 2006
Headquarters Laval, Canada Not tracked yet
Employees 30 7
Industry Biotechnology Biotechnology
Funding Stage Not tracked yet Series Unknown
Total Funding Not tracked yet $3.45B
Funding Rounds Not tracked yet 5
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Regenerative Medicine, Stem Cell Therapies, Liver Disease, Liver Failure, Engineered Tissues, Biomedical Research, Pediatric Transplant Hepatology, Cell Therapy, Medical Innovation, Clinical Trials, Healthcare Startups, Medical Technology, Healthcare Industry Regenerative Medicine, Stem Cells, Tissue Repair, Drug Development, Innovation, Biomedical Technology, Tissue Regeneration, Medical Research, Healthcare Innovation
Website morphocell.com stemrim.com
Morphocell Technologies logo

About Morphocell Technologies

Morphocell Technologies is a biotechnology startup founded in 2018 in Canada. The company focuses on regenerative medicine, specifically the development and commercialization of stem cell therapies and engineered tissues targeting liver failure. As a spin-off from the Hepatology and Cell Therapy lab...

(株)ステムリム logo

About (株)ステムリム

StemRIM is a pioneering biotechnology company founded in 2006 with a focus on regenerative medicine. Their slogan, "Pioneering regenerative medicine by harnessing the body's own stem cells to repair and rejuvenate damaged tissues," encapsulates their mission. StemRIM is driving innovation by creatin...

Frequently Asked Questions

Morphocell Technologies — Transforming the treatment of liver disease. (株)ステムリム — Pioneering regenerative medicine by harnessing the body's own stem cells to repair and rejuvenate damaged tissues.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Morphocell Technologies has raised undisclosed funding while (株)ステムリム has raised $3.45B.
Morphocell Technologies and (株)ステムリム operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors Morphocell Technologies, (株)ステムリム, and millions of companies for 40+ signal types.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy